Skip to content

Consideration of the validity of the medicine treatment of artificial knee joint replacement chronic postsurgical pain (searching study)

Consideration of the validity of the medicine treatment of artificial knee joint replacement chronic postsurgical pain (searching study) - chronic postsurgical pain in TKA(medicine treatment)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045516
Enrollment
105
Registered
2021-10-20
Start date
2021-10-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic postsurgical pain

Interventions

TRAMCET Combination Tablets Cymbalta Capsules TRAMCET Combination Tablets and Cymbalta Capsules

Sponsors

Kamagaya General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The patient who carried out TKA to OA 2)The patient who fills following all which is a definition of chronic postsurgical pain as of 3 months after an operation 1,The pain appears after surgery-like operation. 2,The pain is continuing for 2 months at least after an operation of TKA to OA. 3,The pain by the other cause can be excluded. 4,The pain besides the operation part which existed before the way can be excluded. 3)Patient who possesses sharp pain VAS >= 30 (0-100) as of 3 months after an operation 4)the patient of whom walking is independent 5)the age of the time of the agreement merit, more than 20-year-old patient(I don't ask about the gender.) 6)the patient who could get documentary consent by free will of the back and the patient person himself which had the enough explanation in case of participation of this research

Exclusion criteria

Exclusion criteria: 1)the patient who is planning to carry out TKA in simultaneousness of left and right 2)patient with a spirit disease 3)patient with taboo and TRAMCET Combination Tablets and Cymbalta Capsules 4)additionally the patient who judged that a study person in charge was unsuitable as a subject of research person

Design outcomes

Primary

MeasureTime frame
The change which is sharp pain VAS in 3 months after the medicine treatment starting time and starting

Countries

Japan

Contacts

Public ContactTakeshi Mochizuki

Kamagaya General Hospital Plastic surgery

chiken@kamagaya-hp.jp047-498-8266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026